Davidson Kempner Capital Management Lp

Q1 2020 13F Holdings Report, New Holdings, Stock Holdings

Signature - Title
Eric Sacks - Chief Financial Officer
Location
New York
Holdings as of
31 Mar 2020
Value $
$50.7M
Num holdings
1
Date filed
14 Aug 2020, 15:24
Form type
13F-HR/A-3 - New Holdings
Description
Top holdings included QGEN. Request for Confidential Treatment (15 May 2020): Confidential Treatment Expired on 15 Nov 2021.
Previous filing
Q4 2019 - 14 Feb 2020
Next filing
Q2 2020 - 14 Aug 2020
SEC
View on sec.gov
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

This filing lists securities holdings reported on the form 13F filed on 15 May 2020 pursuant to a request for confidential treatment and for which confidential treatment expired on 15 Nov 2021.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Eric Sacks Chief Financial Officer New York, New York 12 Aug 2020